Genetic risk score for heart disease and health habits
Part of Heart & circulation clinical trials.
This study looks at whether sharing a genetic risk score for heart disease can help people make heart-healthy changes. If you're not on cholesterol medication, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 30 and 75 years old.
- You have a primary care doctor at Mass General Brigham and have seen them in the past 2 years.
- You are not currently taking any cholesterol-lowering medication, like statins.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a polygenic risk score to see if knowing your genetic risk for coronary artery disease can help prevent a first heart attack. If you have an intermediate 10-year risk and no prior heart events, you may be eligible.
This study follows people to understand heart disease risk by combining a heart risk score with genetic risk (polygenic risk). It may help improve how doctors identify who is at higher risk and could guide prevention planning.
This study looks for genetic (DNA) clues that may help predict side effects or complications after heart surgery. If you join, your genome information may be used to understand who is at higher risk and why.
This trial looks at how learning about your genetic risk for heart disease might help prevent it. You will get a personalized report and guidance.
This trial looks at an individualized prevention approach for people who are at higher risk of heart and blood vessel problems. It aims to help lower future cardiovascular risk before heart disease develops.
This trial uses your genetic risk score and a CT scan of your heart to see if changing how doctors manage your diabetes can lower your risk of heart problems. It is for adults with type 2 diabetes who haven't had heart disease symptoms.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.